Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007;99:44i 55i. 8.3.1. Follow-Up After Initiating Antihypertensive Drug Therapy S8.3.1-1. Ambrosius WT, Sink KM, Foy CG, et al. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials. 2014;11:532 46. S8.3.1-2. Cushman WC, Grimm RH Jr, Cutler JA, et al. Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007;99:44i 55i. S8.3.1-3. Xu W, Goldberg SI, Shubina M, et al. Optimal systolic blood pres- sure target, time to intensification, and time to follow-up in treat- ment of hypertension: population based retrospective cohort study. BMJ. 2015;350:h158. 8.3.2. Monitoring Strategies to Improve Control of BP in Patients on Drug Therapy for High BP S8.3.2-1. Brennan T, Spettell C, Villagra V, et al. Disease management to promote blood pressure control among African Americans. Popul Health Manag. 2010;13:65 72. S8.3.2-2. Bosworth HB, Olsen MK, Grubber JM, et al. Two self-management interventions to improve hypertension control: a randomized trial. Ann Intern Med. 2009;151:687 95. S8.3.2-3. Bosworth HB, Powers BJ, Olsen MK, et al. Home blood pres- sure management and improved blood pressure control: results from a randomized controlled trial. Arch Intern Med. 2011;171: 1173 80. S8.3.2-4. Green BB, Cook AJ, Ralston JD, et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008;299:2857 67. S8.3.2-5. Heisler M, Hofer TP, Schmittdiel JA, et al. 